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Wild-living African apes are endemically infected with parasites
that are closely related to human Plasmodium vivax, a leading cause
of malaria outside Africa. This finding suggests that the origin of P.
vivaxwas in Africa, even though the parasite is now rare in humans
there. To elucidate the emergence of human P. vivax and its rela-
tionship to the ape parasites, we analyzed genome sequence data
of P. vivax strains infecting six chimpanzees and one gorilla from
Cameroon, Gabon, and Côte d’Ivoire. We found that ape and hu-
man parasites share nearly identical core genomes, differing by
only 2% of coding sequences. However, compared with the ape
parasites, human strains of P. vivax exhibit about 10-fold less di-
versity and have a relative excess of nonsynonymous nucleotide
polymorphisms, with site-frequency spectra suggesting they are
subject to greatly relaxed purifying selection. These data suggest
that human P. vivax has undergone an extreme bottleneck, fol-
lowed by rapid population expansion. Investigating potential
host-specificity determinants, we found that ape P. vivax parasites
encode intact orthologs of three reticulocyte-binding protein genes
(rbp2d, rbp2e, and rbp3), which are pseudogenes in all human P.
vivax strains. However, binding studies of recombinant RBP2e and
RBP3 proteins to human, chimpanzee, and gorilla erythrocytes
revealed no evidence of host-specific barriers to red blood cell in-
vasion. These data suggest that, from an ancient stock of P. vivax
parasites capable of infecting both humans and apes, a severely
bottlenecked lineage emerged out of Africa and underwent rapid
population growth as it spread globally.
Plasmodium vivax | genomics | malaria | great apes | zoonotic transmission
The protozoal parasite Plasmodium vivax causes over 8 millioncases of human malaria per year, with the great majority
occurring in Southeast Asia and South America (1). P. vivax is
rare in humans in Africa due to the high prevalence of the Duffy-
negative mutation (2), which abrogates expression of the Duffy
antigen receptor for chemokines (DARC) on erythrocytes. Since
DARC serves as a receptor for P. vivax, its absence protects Duffy-
negative humans from P. vivax infection (3), although this pro-
tection is not absolute (4). Until recently, P. vivax was thought to
have emerged in Asia following the cross-species transmission of a
macaque parasite (5, 6). However, the finding of closely related
parasites in wild-living chimpanzees and gorillas suggested an
African origin of P. vivax (7). Indeed, parasite sequences closely
resembling P. vivax have been detected in western (Pan troglodytes
verus), central (Pan troglodytes troglodytes), and eastern (Pan
troglodytes schweinfurthii) chimpanzees, eastern (Gorilla beringei
graueri) and western lowland (Gorilla gorilla gorilla) gorillas, and
most recently in bonobos (Pan paniscus) (7–11). Phylogenetic
analyses of available sequences revealed that ape and human
parasites were nearly identical, with human P. vivax sequences
forming a monophyletic lineage that usually fell within the radia-
tion of the ape parasites (7). These findings suggested that P. vivax
infected apes, including humans, in Africa, until the spread of the
Duffy-negative mutation largely eliminated the parasite in humans
there. However, definitive conclusions could not be drawn, since
all analyses of ape P. vivax genomes to date have rested on a small
number of gene fragments amplified almost exclusively from
parasite mitochondrial DNA present in ape fecal samples.
Significance
Chimpanzees, bonobos, and gorillas harbor close relatives of
human Plasmodium vivax, but current knowledge of these
parasites is limited to a small number of gene fragments derived
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binding. The results showed that ape parasites are 10-fold more
diverse than human P. vivax and exhibit no evidence of species
specificity, whereas human P. vivax represents a bottlenecked
lineage that emerged from within this parasite group. Thus,
African apes represent a large P. vivax reservoir whose impact
on human malaria eradication requires careful monitoring.
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Understanding the origin of human P. vivax and its relation-
ship to the ape parasites is important for several reasons. First,
only six Plasmodium species, out of several hundred so far de-
scribed as infecting vertebrate hosts (12), have successfully col-
onized humans (13). Thus, the circumstances that surround the
emergence of each of these human pathogens are of interest,
especially since most, if not all, have nonhuman primate para-
sites as their closest relatives (7, 9, 14). Second, it is currently
unclear whether the ape parasites represent a separate species
distinct from P. vivax. Although sequences from human P. vivax
parasites form a monophyletic clade in phylogenetic trees, this
may reflect their geographic separation and not the existence of
host-specific infection barriers. Indeed, ape P. vivax has been
shown to cause malaria in a Duffy-positive European traveler
(11), and human P. vivax has been transmitted to wild-living
monkeys in South America, generating what has been called
“Plasmodium simium” (15). If cross-species infection and re-
combination of ape and human P. vivax are possible, as appears
to be the case for P. simium and P. vivax in South America (15,
16), this could have implications for malaria-eradication efforts.
Finally, ape and human P. vivax strains may have acquired ad-
aptations that limit parasite transmission between different host
species. Such findings could explain why the macaque parasites
Plasmodium knowlesi and Plasmodium cynomolgi can infect and
cause malaria in humans but do not appear to be commonly
transmitted between different human hosts (17).
To elucidate the events that led to the emergence of human P.
vivax, we sought to obtain genome sequences of parasites infecting
chimpanzees and gorillas. A similar approach has recently un-
covered processes that may have allowed the gorilla precursor of
Plasmodium falciparum to cross the species barrier to infect
humans (18, 19). However, obtaining blood samples from
Plasmodium-infected apes is challenging due to the endangered
species status of these hosts. Moreover, ape P. vivax, like its
human-infecting counterpart, exhibits only low levels of para-
sitemia (7) and has not been cultured. Although removal of host
leukocytes from whole-blood samples (20) and parasite nucleic
acid capture (21) have improved the recovery of human P. vivax
genomes, these approaches are not readily applicable to ape
parasites. We thus adapted a previously developed selective
whole-genome amplification (SWGA) method (18) to generate
P. vivax genome sequences from unprocessed chimpanzee and
gorilla blood samples obtained in different parts of Africa. Anal-
ysis of these genomes revealed that the ape parasites are about
10 times more diverse than global representatives of human
P. vivax (21), indicating that the human parasite has undergone a
severe genetic bottleneck. Ape P. vivax genomes were found to
have intact orthologs of three reticulocyte-binding protein (RBP)
genes that are pseudogenized in all human P. vivax strains, but
functional studies of two of the encoded proteins revealed no
evidence of species-specific receptor interactions. The P. vivax
ancestor therefore likely infected both humans and apes in Africa
before being eliminated in humans there by the spread of the
Duffy-negative mutation, while the current human-infecting par-
asites represent a lineage that had escaped out of Africa.
Results
Genome Assemblies of Chimpanzee P. vivax. Leftover blood samples
from routine health examinations of chimpanzees cared for at
the Sanaga-Yong (SY) Chimpanzee Rescue Center in Cameroon
were screened for Plasmodium infection using nested PCR with
pan-Plasmodium and P. vivax-specific primers. Two samples,
SY56 and SY43, were positive for ape P. vivax, with limiting-
dilution PCR detecting one strain in SY56 and up to five vari-
ants in SY43, with two strains predominating. Since these two
samples lacked other Plasmodium species, they were suitable for
SWGA without the risk of generating interspecies recombinants
(18, 22). SWGA uses the highly processive phi29 DNA poly-
merase and specific primers to preferentially amplify pathogen
sequences from complex mixtures of target and host DNA and
has been used successfully in the past to generate Plasmodium
sequences from blood smear negative, unprocessed blood sam-
ples (18). Since SWGA can result in stochastic amplification
when target templates are rare (18, 23), each sample was am-
plified on more than one occasion using different primer sets,
with and without digestion of sample DNA with methylation-
dependent restriction enzymes to degrade host DNA (SI Ap-
pendix, Table S1). Individual SWGA reactions were pooled and
sequenced on Illumina and PacBio platforms (SI Appendix).
Draft genomes of the chimpanzee P. vivax strains PvSY56 and
PvSY43 were generated using iterative reference-guided assem-
bly to the human PvP01 reference genome (24) followed by gap-
filling steps. In addition, PvSY56 reads that did not map to the
PvP01 core genome were de novo assembled to obtain sub-
telomeric contigs. The resulting assemblies yielded 21.9 Mbp and
21.2 Mbp of sequence for PvSY56 and PvSY43, respectively
(Table 1). Because sample SY43 contained at least five P. vivax
strains (7), the PvSY43 genome represents a consensus of these
variants. Annotations were transferred from PvP01, with addi-
tional genes predicted in the de novo contigs. Since a large
number of genes contained frameshifts in homopolymer tracts,
we manually corrected annotations spanning these presumed
Table 1. Genome features of ape P. vivax
Genome attributes PvSY56 PvSY43* PvP01†
Host species Chimpanzee Chimpanzee Human
Country Cameroon Cameroon Indonesia
Chromosomal assembly‡, bp 21,928,114 21,224,756 24,177,188
Mean depth of coverage§ 319 240 N/A
Chromosomal contigs 7,112 6,604 14
G + C content, % 44.1 44.6 43.3
Core protein-coding genes¶ (% of PvP01) 4,883 (98.8) 4,908 (99.3) 4,941 (100)
Full length# (% of PvP01) 4,391 (88.9) 4,350 (88.0) N/A
Partial (% of PvP01) 492 (10.0) 558 (11.3) N/A
Genes in hypervariable regions¶ 415 276 1,702
N/A, not applicable.
*The genome assembly of PvSY43 represents a consensus sequence of at least two major and three minor
chimpanzee P. vivax variants (Fig. 2 C and D and SI Appendix, Fig. S5).
†Chimpanzee P. vivax genomes were compared with the human P. vivax reference PvP01 (24).
‡Number of unambiguous bases.
§Calculated by dividing the number of nucleotides in reads mapped to the assemblies by the expected genome
size from PvP01.
¶Subtelomeric, core and internal hypervariable regions were defined as described (20).
#Genes classified as full length comprised at least 90% of the length of the corresponding PvP01 ortholog.
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sequencing errors to maintain an ORF. Overall, PvSY56 and
PvSY43 shared a highly conserved core genome with human
P. vivax. More than 98% of PvP01 core genes (as defined in ref.
20) were identified in each chimpanzee P. vivax assembly (Table
1), with 88% present as full-length genes. Although 10 human P.
vivax core genes were absent from both PvSY56 and PvSY43, ape
P. vivax reads at least partially covered these coding regions, im-
plicating assembly difficulties rather than differences between ape
and human P. vivax genomes as the reason for their absence.
Assembly issues likely also account for the small number of genes
in subtelomeric and internal hypervariable regions that could be
annotated for PvSY56 and PvSY43 (Table 1).
Polymorphism in Ape and Human P. vivax. Comparison of coding
sequences between the PvSY56 and PvSY43 assemblies revealed
that they differ at 0.61% of sites, in contrast with a difference of
only 0.11% between the two human P. vivax reference genomes,
PvSalI and PvP01 (SI Appendix, Fig. S1A). Since PvSY56 and
PvSY43 were derived from chimpanzees housed at the same
sanctuary, we reasoned that they might not represent the full
extent of ape P. vivax diversity (the two human reference strains
were sampled on two different continents, in Latin America and
Southeast Asia). This prompted us to obtain P. vivax genome
sequences from additional infected apes. Using SWGA followed
by Illumina sequencing, we amplified ape P. vivax from blood
samples of two additional SY chimpanzees (SY81 and SY90),
from a wild-living western chimpanzee (Sagu) from Côte d’Ivoire
(10), and from a western lowland gorilla (Gor3157) sampled in
Cameroon (SI Appendix, Table S2). We also mined the read
database from a blood sample of a Plasmodium malariae-infected
sanctuary chimpanzee from Gabon (14), which we had noted
contained a substantial number of ape P. vivax reads. Reads from
each sample were mapped to the PvSY56 assembly, and SNPs
were identified. The extent of genome coverage varied consider-
ably among the six chimpanzee samples; however, we were able to
recover between 695 and 3,005 core genes (SI Appendix, Table S2),
with 65% of genes analyzed being covered in four or more parasite
genomes (SI Appendix, Fig. S2). The gorilla P. vivax strain, which
was derived from a partially degraded bushmeat sample, yielded
only 10 genes despite repeated amplification and thus was not
included in the diversity analysis. For comparison, we included
sequences from seven additional human P. vivax strains (21), each
from a different country (India, Myanmar, Papua New Guinea,
Thailand, Colombia, Mexico, and Peru), and identified SNPs using
the same methods. Diversity values were then calculated across a
common set of 4,263 core genes for which we obtained sequences
from two or more strains for both ape and human P. vivax (Table
2). The results revealed a mean pairwise nucleotide sequence di-
versity (π) among the six chimpanzee P. vivax strains of 0.698%,
about eight times higher than the value (0.085%) for the global
sample of human strains (Fig. 1A, Table 2, and SI Appendix, Fig.
S1B). Removal of the PvSY43 sequence did not decrease this
difference (SI Appendix, Fig. S1C), indicating that the inclusion of
this multiply infected sample did not inflate the diversity of the
chimpanzee P. vivax parasites. Furthermore, analysis of transition/
transversion ratios at fourfold degenerate sites yielded nearly
identical results for chimpanzee (1.08) and human (1.07) P. vivax
strains, excluding the possibility of an SWGA-related increase in
diversity. Thus, the much higher level of diversity among chim-
panzee P. vivax strains, compared with parasites currently circu-
lating in humans, does not appear to be an artifact.
The nature of the nucleotide polymorphisms also differed
substantially between chimpanzee and human P. vivax strains.
Among the chimpanzee parasites the majority of polymorphisms
were synonymous, with the ratio of nonsynonymous to synony-
mous SNPs (NS/S) being 0.68. In contrast, the majority of
polymorphisms among the human strains were nonsynonymous,
with an NS/S ratio of 1.37 (Table 2). The NS/S ratio among
polymorphisms can be compared with (i.e., divided by) the NS/S
ratio among interspecies differences to yield the neutrality index
(NI) (25). This NI assumes that synonymous changes, both
within and between species, are selectively neutral and has an
expected value of one when nonsynonymous changes are also
neutral. We thus compiled a set of 3,913 genes that were com-
parable among ape and human P. vivax strains as well as between
these parasites and the macaque parasite P. cynomolgi (their
closest relative with an available genome sequence). The overall
NI value for ape P. vivax strains was close to the neutral ex-
pectation (NI = 0.96) (SI Appendix, Table S3). In contrast, the
overall value for human P. vivax strains was much larger, NI =
1.91, indicating a large excess of nonsynonymous polymorphisms
among human strains relative to the expectation derived from
patterns of divergence between species.
Comparison of the ratios of nonsynonymous and synonymous
changes between within-species polymorphisms and between-
species fixed differences forms the basis of the McDonald–
Kreitman (MK) test for adaptive evolution of individual genes
(26). The discrepancy in overall NI values for ape versus human
P. vivax strains indicates that MK tests are likely to produce dif-
ferent results depending on which P. vivax strains are used. For the
chimpanzee P. vivax strains, only two genes yielded significant
results after correction for multiple testing (P < 0.05), both with
NI <1 indicating a significant excess of fixed, potentially adaptive,
nonsynonymous differences: one was found to be orthologous to
PVP01_1201800, which is an immunogenic member of the
tryptophan-rich antigen family of P. vivax (27, 28), and the other
(orthologous to PVP01_1406200) encodes a conserved Plasmo-
dium protein of unknown function. For the human P. vivax strains,
five genes yielded significant MK test results, but all with NI >1,
indicating an excess of nonsynonymous polymorphisms (Dataset
S1). Such results are usually interpreted as evidence of balancing
selection maintaining polymorphism, but the large overall NI
value for the human strains suggests that a more pervasive factor,
such as past demography, is influencing these genes. Fig. 1B shows
the distributions of NI values for 1,585 individual genes with non-
zero values in both ape and human P. vivax. These results indicate
that the difference between ape and human P. vivax is not due to a
subset of unusual genes but rather that the entire distribution is
shifted from being centered around 1.0 in ape P. vivax to being
centered around 2.0 in human P. vivax (Fig. 1B and Dataset S1).
To look for possible human-specific adaptive changes, we also
performed MK tests for 4,263 core genes comparing polymorphisms
Table 2. Nucleotide polymorphism in ape and human P. vivax
Parasites n* πall† π0‡ π4§ NS polymorphisms¶ S polymorphisms¶ NS/S
Ape P. vivax 6 0.00698 0.00357 0.01604 32,364 47,494 0.68
Human P. vivax 9 0.00085 0.00060 0.00143 10,530 7,673 1.37
*n = number of strains included in the analysis (see SI Appendix, Fig. S2 for gene coverage among the different
strains).
†Mean pairwise diversity at coding sites from 4,263 genes (6.5 million sites).
‡Mean pairwise diversity at zerofold degenerate sites from 4,263 genes (4.0 million sites).
§Mean pairwise diversity at fourfold degenerate sites from 4,263 genes (0.7 million sites).
¶Numbers of nonsynonymous (NS) and synonymous (S) polymorphisms were calculated by counting the number
of SNPs that changed (NS) or did not change (S) the protein sequence of the respective reference (PvSY56 for ape
P. vivax; PvP01 for human P. vivax).
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within ape P. vivax with fixed differences between ape and
human P. vivax. After correcting for multiple tests, we found no
genes with a significant excess of nonsynonymous fixed differ-
ences. While this may seem surprising, the timespan since the
human lineage of P. vivax became restricted to this host may
have been too short for the accumulation of a sufficient number
of adaptive changes to yield significant test results, and this
finding does not exclude the possibility that smaller numbers of
adaptive changes have indeed occurred.
To investigate the unusual pattern of nucleotide polymorphisms
in human P. vivax in greater detail, we examined the frequencies
of nonsynonymous and synonymous polymorphisms per site. We
obtained different results depending on the methodology used,
primarily because different methods use different approaches to
estimate the numbers of sites available for synonymous changes.
To avoid this problem, we included only fourfold and zerofold
degenerate sites where, due to the structure of the genetic code,
either all or none of the possible changes are synonymous. Among
ape P. vivax strains, the nucleotide diversity at zerofold degenerate
sites (0.357%) was 22% of that at fourfold degenerate sites
(1.604%), whereas among human P. vivax strains, the value at
zerofold degenerate sites (0.060%) was 42% of that at fourfold
degenerate sites (0.143%) (Table 2 and SI Appendix, Fig. S1D and
E). Thus, while chimpanzee parasites were 11 times more diverse
than human parasites at fourfold degenerate sites, they were only
six times more diverse at zerofold degenerate sites, indicating that
nonsynonymous polymorphisms in human P. vivax strains are al-
most twice as numerous as expected.
A large number of human P. vivax genome sequences have
been characterized (20, 21), so it is possible to investigate the
frequencies at which SNPs are segregating within the population.
Synonymous polymorphisms are expected to be neutral, so their
site frequency spectrum (SFS) should reflect past demography.
By comparison, many nonsynonymous polymorphisms are
expected to be slightly deleterious, and their SFS thus should be
more skewed toward lower frequencies (29). To examine a large
number of parasite sequences from a single geographic region,
we focused on SNP data from Malaria Genomic Epidemiology
Network (MalariaGen) samples from Southeast Asia (20). An-
cestral and derived alleles at each site were identified by com-
parison with two outgroups: the chimpanzee P. vivax strain
PvSY56 and a P. cynomolgi reference strain. The unfolded site
frequency spectra obtained for SNPs at zerofold and fourfold
degenerate sites are almost identical (Fig. 1C). Thus, the un-
usually large fraction of nonsynonymous polymorphisms among
human P. vivax sequences appears to reflect mutations that are
segregating as effectively neutral alleles.
Relationship of P. vivax Strains from Humans and Apes. In previous
analyses of a small number of partial gene sequences, we found
that sequences from human P. vivax parasites always formed a
monophyletic clade, which usually fell within the radiation of se-
quences from chimpanzee and gorilla samples (7). This was ob-
served for mitochondrial and apicoplast sequences as well as for
three nuclear genes, while for a fourth nuclear gene the ape and
human P. vivax sequences formed sister clades (7). Here we found
that, across their genome, chimpanzee parasites were much more
divergent from the human parasites than they were from each
other. For example, across 3,958 core genes, the chimpanzee
parasite genomes PvSY56 and PvSY43 differed from one another
at 0.6% of sites but differed from the human P. vivax reference
genomes PvSalI and PvP01 at 2.2% of sites on average. This re-
lationship is summarized in a neighbor-joining tree constructed
from a matrix of pairwise genetic distances from an alignment of
241 nuclear genes available for all six chimpanzee parasites (Fig.
2A). Although this tree may not reflect the true evolutionary his-
tory of any one particular gene (due to recombination), the overall
relationships were confirmed in a phylogenetic network (SI Ap-
pendix, Fig. S3A), which showed that the chimpanzee parasites
sampled at the same location (SY) in Cameroon are on average a
little more closely related to each other than they are to the strains
identified in Gabon (GA02) and Côte d’Ivoire (Sagu). Inclusion of
P. vivax sequences from the gorilla sample restricted the analysis to
six genes and only five chimpanzee parasites. For these genes the
gorilla P. vivax strain was quite divergent (Fig. 2B and SI Appendix,
Fig. S3B), differing almost as much from the chimpanzee strains
(on average 1.8%) as from the human strains (on average 2.4%).
Whether the human P. vivax lineage falls within the radiation of
the ape strains or groups as a sister clade depends on the position
of the root of these trees. The closest available outgroup is
P. cynomolgi, which is much more distant from the P. vivax sequences
than they are from each other and may not root the tree reliably.
To investigate further the relationships among ape and human
P. vivax strains, we focused on the 10 genes that could be re-
covered from the single gorilla sample (SI Appendix, Table S2).
Including both P. cynomolgi and P. knowlesi as outgroups, we
found that four genes yielded a tree topology in which the human
strains fell within the radiation of ape strains, while the six other
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Fig. 1. Nucleotide sequence diversity in ape and human P. vivax. (A) The π calculated across a common set of 4,260 core genes for six chimpanzee and nine
human P. vivax strains (as in Table 2, but three genes with fewer than 35 aligned sites were excluded). Median and mean (weighted by gene length) π values
are indicated by solid and dashed lines, respectively; box and whiskers indicate the interquartile range and 99th percentiles, respectively. Plots including
outliers are shown in SI Appendix, Fig. S1B. (B) Density plots of NI values shown on a log2 scale for ape (red) and human (black) P. vivax genes. Values are
shown for 1,585 genes with nonzero values of NI in both populations. (C) Site-frequency spectra of polymorphisms at fourfold degenerate (blue) and zerofold
degenerate (orange) sites extracted from SNP data of human P. vivax samples from Southeast Asia (20).
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genes yielded tree topologies in which human and ape parasites
represented sister clades (SI Appendix, Fig. S4). To increase the
number of geographically diverse ape P. vivax sequences, we
used single genome amplification (SGA) to screen an existing
collection of P. vivax-positive ape blood and fecal samples for
five of these genes (SI Appendix, Fig. S5). Each DNA prepara-
tion was diluted so that only single DNA templates were am-
plified, which precludes in vitro recombination. For three of
these genes, this analysis also yielded sequences from Plasmo-
dium carteri, a rare parasite species thus far found in only two
wild chimpanzees, which is distinct from but most closely related
to the P. vivax clade (7, 30). When these additional sequences
were included in the phylogenetic analyses, four of the five trees
showed the human strains within the radiation of ape strains,
including two in which the previous topology depicted ape and
human strains as sister clades, with three of these four trees in-
cluding gene sequences for P. carteri (Fig. 2C and SI Appendix,
Fig. S6). Thus, the inclusion of gorilla P. vivax and/or P. carteri
changed the topology from sister clades to a nested relationship.
For the remaining gene, human and ape parasite sequences
remained as sister clades, but only a single gorilla parasite se-
quence was available for analysis, and P. carteri sequences could
not be amplified (Fig. 2D). These results indicate that the
inferred relationships among P. vivax strains from apes and hu-
mans depend in large part on the number of available sequences,
especially from gorilla parasites, as well as on the presence of a
closely related outgroup.
Ape P. vivax Strains Maintain ORFs for rbp Genes That Are Pseudogenized
in Human P. vivax. Adaptation of Plasmodium parasites to new
host species has been associated with gains and losses of genes
encoding proteins involved in red blood cell invasion (13). We
therefore compared the repertoire of P. vivax invasion genes in
the genomes of human and chimpanzee parasites. Like human
P. vivax, the chimpanzee parasite genomes contained genes encoding
the Duffy-binding protein (DBP) and a related erythrocyte-
binding protein (DBP2, or EBP) (31), but no additional DBP-
like genes were identified.
Variation in the complement of RBPs is thought to influence
the ability of Plasmodium parasites to invade erythrocytes (13, 32).
Human P. vivax, which exclusively invades reticulocytes, has full-
length ORFs for five rbp genes (rbp1a, rbp1b, rbp2a, rbp2b, and
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Fig. 2. Evolutionary relationships of ape and human P. vivax strains. (A) An unrooted neighbor-joining tree constructed from a matrix of pairwise genetic
distances from an alignment of 241 nuclear genes is shown for nine human (black) and six chimpanzee (red) P. vivax strains (the Inset shows the human
P. vivax strains in greater detail). (B) As in A, but based on six nuclear genes with coverage in one gorilla P. vivax strain (green). The same human and
chimpanzee P. vivax strains were included, except for PvSY81, which did not cover these genes. (C and D) Maximum-likelihood trees for fragments of nuclear
genes PVP01_1418300 (C) and PVP01_1418500 (D) with P. cynomolgi and P. knowlesi included as outgroups. Sequences of P. carteri parasites are shown in
blue. “Pv” denotes sequences from genome-wide analyses, shown in bold if generated by SWGA or derived from published data (SI Appendix, Table S2); all
other sequences except for P. cynomolgi and P. knowlesi were generated by SGA and include a code identifying their geographic origin (SI Appendix, Fig. S5),
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above the trees. The scale bars indicate substitutions per site (see also SI Appendix, Fig. S3 for phylogenetic network representations).
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rbp2c), all of which were conserved in the two chimpanzee P. vivax
genomes PvSY56 and PvSY43. Two shorter rbp genes annotated
in human P. vivax (rbp2p1 and rbp2p2) are believed to encode
proteins that lack a C-terminal transmembrane domain; one of
these, rbp2p1, appears to be present in all human P. vivax strains
and also in P. cynomolgi, while rbp2p2 has been found only in a
subset of human P. vivax strains (33). We identified orthologs of
both of these partial genes in the chimpanzee P. vivax genomes
(Fig. 3A), indicating that variation in the presence of rbp2p2
among human P. vivax strains is the result of a deletion after the
divergence of human and ape parasites rather than a recent gene
duplication. The finding of partial rbp2p1 and rbp2p2 genes in
both ape and human P. vivax and of rbp2p1 in P. cynomolgi sug-
gests that their encoded proteins have a conserved function.
However, synonymous-to-nonsynonymous substitution (dN/dS)-
based tests for positive selection (34) in invasion genes on the
branch leading to human P. vivax (dbp, ebp, rbp1a, rbp1b, rbp2a,
and rbp2b) failed to yield evidence of human-specific adaptation.
The human P. vivax genome also contains three rbp pseudogenes
termed rbp2d, rbp2e, and rbp3. Seemingly functional orthologs
of rbp2e and rbp3 are present in the genomes of the monkey
parasites P. cynomolgi, P. knowlesi, and Plasmodium inui, while
Plasmodium fragile has an intact rbp2e gene but a rbp3 pseudogene
(Fig. 3A). So far, rbp2d has been identified only in P. vivax. The two
chimpanzee P. vivax genomes PvSY56 and PvSY43 contained full-
length intact ORFs corresponding to each of these three human P.
vivax pseudogenes, indicating that the loss of function occurred
after the divergence of human and ape parasites (Fig. 3A).
Since the pseudogenization of rbp2d, rbp2e, and rbp3 seems to
be unique to the human lineage of P. vivax, we considered the
possibility that these genes may be intact in some human strains.
We mapped sequencing reads from 374 published human
P. vivax strains (20, 21) to the rbp2d, rbp2e, and rbp3 reference
genes and analyzed those that yielded a greater than threefold
read coverage of the entire coding sequences. In each gene, we
found at least one inactivating mutation that was present in all
human parasite samples as well as numerous additional mutations
that likely occurred subsequent to the initial pseudogenization
event (Fig. 3B). The accumulation of additional frameshifts and
stop mutations, some of which occur very close to the 5′ end of
the coding sequence, suggests that these genes do not encode
truncated proteins.
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Fig. 3. The rbp gene family in ape and human P. vivax. (A) A midpoint-rooted maximum-likelihood phylogenetic tree is shown depicting the relationships of
human (black) and chimpanzee (PvSY56 and PvSY43, red) P. vivax rbp genes with their orthologs in P. knowlesi, P. cynomolgi, P. inui, P. fragile, and human P.
malariae (purple). P. vivax, P. cynomolgi, and P. knowlesi genes are labeled according to their published names; genes from P. inui, P. fragile, and P. malariae
are labeled according to the clade in which they are placed. Pseudogenes are indicated by yellow stars. The Inset shows the relationship of rbp1a sequences
among representative human and three sequenced chimpanzee P. vivax strains, rooted using P. cynomolgi (see SI Appendix for details). (B) Locations of
frameshift (purple) and premature stop (black) mutations in rbp2d, rbp2e, and rbp3 sequences assembled from published human P. vivax strains (20, 21),
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To examine whether the other chimpanzee P. vivax strains (SI
Appendix, Table S1) contained any of the rbp2d-, rbp2e-, and rbp3-
inactivating mutations, we mapped available sequencing reads to
the respective PvSY56 genes. We also used SGA to amplify the
same regions from P. vivax-positive gorilla samples. Although in
most instances the coverage of the rbp2d, rbp2e, and rbp3 genes
was incomplete, none of the recovered sequences contained the
frameshift and stop codon mutations found in all human P. vivax
strains (SI Appendix, Fig. S7). This was also true for SGA-derived
gorilla parasite sequences from the multiply infected SAggg3157
sample, which contained a number of polymorphisms, none of
which disrupted the respective reading frame. Thus, both chim-
panzee and gorilla P. vivax parasites appear to maintain three
genes encoding RBPs that have been lost in all human P. vivax
strains, which could influence their host tropism.
Recombinant RBP2e and RBP3 Do Not Exhibit Species-Specific Red
Blood Cell Binding. The pseudogenization of rbp2d, rbp2e, and
rbp3 in all human P. vivax strains raised the possibility that these
proteins bind gorilla- and/or chimpanzee-specific erythrocyte
receptors that are no longer used by the human parasite.
Recombinant proteins comprising the N-terminal domain of
RBPs encoded by human P. vivax (RBP2a160–1000 and RBP2b161–969)
have been used to characterize their erythrocyte-binding prop-
erties (35, 36). These studies showed that RBP2b binds the
reticulocyte-specific transferrin receptor 1 (TfR1), also termed
“CD71” (35), while RBP2a binds an unknown receptor pre-
sent on both normocytes and reticulocytes (36). To examine
the function of chimpanzee P. vivax RBP2d, RBP2e, and
RBP3 proteins, we expressed their N-terminal domains in bac-
teria for subsequent erythrocyte-binding studies. Although
RBP2d165–967 could not be purified due to protein aggregation,
RBP2e156–957 and RBP3149–968 were efficiently expressed and
exhibited an α-helical and β-sheet content similar to human P.
vivax RBP2b (SI Appendix, Fig. S8). Because some RBPs bind
only reticulocytes, we attempted to enrich these cells from blood
samples obtained from four humans, four chimpanzees, and one
gorilla using a Percoll density gradient as previously described
(35, 36). Despite repeated attempts, this approach yielded only
partial reticulocyte enrichment for the ape blood samples, pos-
sibly due to differences in erythrocyte density between the different
species (SI Appendix, SI Materials and Methods). Nonetheless,
some enrichment of ape reticulocytes (up to 1.8%) was achieved
as determined by thiazole orange (TO) staining.
To examine binding to ape red blood cells, we first tested the
two previously characterized human P. vivax RBP proteins,
RBP2a160–1000 and RBP2b161–969 (35, 36). Ape and human red
blood cells were incubated with each recombinant protein, and
binding was assessed using protein-specific polyclonal rabbit an-
tibodies followed by a fluorophore-labeled anti-rabbit antibody
(35, 36). Reticulocytes were stained with TO before flow cytom-
etry (Fig. 4A). Consistent with previous results, we observed ro-
bust binding of RBP2a to both human normocytes (10.3% of TO-
negative cells) (Fig. 4B) and reticulocytes (32.4% of TO-positive
cells) (Fig. 4C). Interestingly, a similar binding profile was ob-
served for gorilla and chimpanzee red blood cells (Fig. 4 and SI
Appendix, Fig. S9). As expected, RBP2b exhibited a strong pref-
erence for reticulocytes, binding 19.9% of human reticulocytes
(Fig. 4C) but only a minor fraction (0.9%) of human normocytes
(Fig. 4B), likely reflecting incomplete reticulocyte staining and/or
nonspecific binding. RBP2b also bound chimpanzee and gorilla
reticulocytes, albeit at a reduced level (Fig. 4C). Although the
TfR1 proteins of chimpanzees and gorillas differ from their hu-
man counterpart by a few amino acids (SI Appendix, Fig. S10),
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Fig. 4. Binding of RBPs to ape and human red blood cells. (A) Dot plots depict the binding of human P. vivax RBP2a and RBP2b proteins and chimpanzee P.
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none of these residues was identified as representing critical
RBP2b contact sites (37). Thus, the decreased binding of RBP2b
to ape reticulocytes is unlikely to be the result of sequence dif-
ferences between chimpanzee, gorilla, and human TfR1 proteins
and may instead reflect differences in TfR1 expression levels,
posttranslational modifications, or other factors.
Having validated the experimental system, we next tested the
binding of chimpanzee P. vivax RBP2e156–957 and RBP3149–968 to
ape and human red blood cells. We found that neither of these two
proteins bound particularly well to ape red blood cells, although
RBP2e consistently yielded a higher signal than RBP3 (Fig. 4 B
and C). Like the human P. vivax RBP2a and RBP2b proteins,
RBP2e and RBP3 appeared to bind reticulocytes more efficiently
than normocytes (Fig. 4 and SI Appendix, Fig. S9). However, there
was no clear evidence for host specificity. Although RBP3 bound
gorilla reticulocytes slightly more efficiently than chimpanzee and
human reticulocytes, this result must be interpreted with caution,
since only a single gorilla sample containing very few reticulocytes
was available for testing (Fig. 4A). Indeed, when red blood cells
from a macaque were tested, RBP2e and RBP3 were found to
bind to reticulocytes from this host species also (SI Appendix, Fig.
S9). To determine whether the low level of RBP2e and
RBP3 binding was due to inefficient reticulocyte enrichment, we
tested an additional chimpanzee blood sample with a particularly
high reticulocyte count. Although Percoll gradient enrichment of
this sample yielded twice as many reticulocytes (4%), this higher
fraction did not improve RBP2e and RBP3 binding (SI Appendix,
Fig. S11). Thus, the maintenance of the rbp2e and rbp3 genes in
chimpanzee P. vivax cannot be readily explained by invoking in-
teraction with a host-specific erythrocyte receptor.
Discussion
It has recently become apparent that wild-living African apes,
including western and eastern gorillas as well as chimpanzees and
bonobos, harbor malaria parasites that appear to be very closely
related to P. vivax strains infecting humans in Asia and Central/
South America (7, 8, 11). Since these results were based on a small
number of mostly mitochondrial DNA fragments, we have now
generated two nearly complete and several partial genome se-
quences from ape-infecting parasites. Analyses of these sequences
show that ape and human parasites are indeed very closely related,
with the human P. vivax sequences forming a monophyletic line-
age either within or as a sister group to the ape parasites. The data
also reveal that ape and human P. vivax strains exhibit distinct
patterns of genetic diversity, reflecting very different demographic
histories. The parasites infecting humans and apes are largely al-
lopatric, but as yet there is no evidence that they represent distinct
Plasmodium species. Thus, P. vivax in African apes represents a
substantial and genetically diverse parasite reservoir from which
future human infections could arise, even if eradication of current
human strains were successful.
Recent papers have emphasized that, across the genome, the
global genetic diversity of human P. vivax is somewhat greater
than that of P. falciparum (21, 38). Here, we find that the level of
neutral genetic diversity among P. vivax parasites from chim-
panzees is about 10 times higher than that of human P. vivax
strains. P. falciparum isolates also exhibit about 10 times less
genetic diversity than is seen in closely related Laverania species
(18, 19). This is consistent with both human parasites having
undergone severe genetic bottlenecks. In the case of P. falcipa-
rum, this most likely occurred at the point when a gorilla parasite
made the cross-species jump into humans (9, 30). For P. vivax, it
is also possible that the ancestral parasites infected only non-
human apes and that one of these crossed the species barrier and
gave rise to the population of parasites currently infecting hu-
mans. Alternatively, ancient P. vivax may have infected all Af-
rican ape species, including humans (7). In the latter case, the
bottleneck would likely have occurred when P. vivax migrated
with humans out of Africa, before the spread of the Duffy-
negative mutation that eliminated P. vivax from humans in
most (or at that time, perhaps all) of sub-Saharan Africa. While
it is difficult to distinguish between these two scenarios on the
basis of genetic data, we believe that the second scenario is the
more likely. Ape P. vivax seems to circulate freely between
chimpanzees and gorillas in the wild (7) and has caused disease
in a Duffy-positive human (11). Consistent with this, the very
high frequency of the Duffy-negative mutation suggests a long
history of P. vivax exerting selective pressure on humans in Africa
(39). It is likely that the geographic areas in which this mutation
is most frequent (2) were influenced over a long timescale by the
distribution of ape P. vivax to which humans were exposed.
The nature of the genetic diversity also differs markedly be-
tween the populations of P. vivax parasites that infect apes and
humans. Among human strains, there is an unusually high frac-
tion of nonsynonymous polymorphism. Moreover, these non-
synonymous polymorphisms exhibit a site-frequency spectrum that
is almost identical to that seen for synonymous mutations, im-
plying that they are segregating as if effectively neutral. Similar
observations have been made for polymorphisms in P. falciparum
(40), where this has been attributed, at least in part, to the re-
peated bottleneck events that the parasite undergoes in every life
cycle at the obligate transmission events between host and vector,
with rapid expansion in the human host (41). Here, we find that
the ratio of nonsynonymous to synonymous mutations among the
much more numerous polymorphisms among ape P. vivax strains
is similar to the ratio at sites of divergence between P. vivax and its
macaque relative P. cynomolgi. Thus, the unusual pattern of
polymorphism in human P. vivax cannot reflect its life cycle but is
more likely the consequence of the population having undergone
a rapid expansion subsequent to the spread out of Africa.
The pseudogenization of three RBPs (rbp2d, rbp2e, and rbp3) in
all human P. vivax strains could be taken to indicate human-
specific adaptation after the parasite migrated out of Africa and
no longer encountered chimpanzees or gorillas. However, our
erythrocyte-binding results are not consistent with this scenario.
We observed equivalent binding of RBP2e to ape and human red
blood cells and only a modest increase in RBP3 binding to gorilla
reticulocytes compared with human reticulocytes. Overall, the
chimpanzee P. vivax-derived RBP2e and RBP3 proteins bound red
blood cells much less well than the human P. vivax-derived RBP2a
and RBP2b proteins, which could be due to low-affinity interac-
tions, improper folding of the recombinant proteins, or the ab-
sence of other parasite proteins required for receptor engagement.
We also considered the possibilities that RBP2e and RBP3 are not
involved in erythrocyte binding or that the core receptor-binding
domains were not included in the expressed proteins. However,
others have shown that the P. knowlesi orthologs of RBP3 and
RBP2e, termed “PkNBPXa” and “PkNBPXb,” both bind red
blood cells (42) and that the binding domain of PkNBPXb maps to
a region included in our RBP2e construct (42). Moreover, deletion
of PkNBPXa severely reduced the ability of P. knowlesimerozoites
to invade human red blood cells in vitro (43), even though all
human-infecting P. vivax strains have lost RBP3. It could be ar-
gued that the large number of RBP genes in P. vivax (eight full-
length and two partial genes) compared with P. knowlesi (two full-
length genes and one pseudogene) provides functional redundancy
that compensates for the loss of rbp genes in human P. vivax.
However, this would also apply to ape P. vivax, where pseudogenes
have not been found. Instead, the loss of rbp genes may be slightly
deleterious and incur a fitness cost. In ape P. vivax, such an
inactivating mutation would likely be selected against and thus not
spread in the population. However, in human P. vivax the same
mutation could be effectively neutral, as many nonsynonymous
mutations appear to be, and so it could survive and drift to fixa-
tion. Whether this explains the loss of rbp2d, rbp2e, and rbp3 in
human P. vivax remains unknown. However, we found no evidence
that rbp2e and rbp3 genes are maintained in ape P. vivax parasites
because they interact with chimpanzee- and/or gorilla-specific
erythrocyte receptors that are absent from human red blood cells.
Despite their common origin in Africa, ape and human
P. vivax populations have likely had little or no geographic
overlap subsequent to the escape of the human-infecting lineage
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out of Africa. Under the bottleneck scenario, the most recent
common ancestor of human P. vivax was in the lineage that
emerged from Africa. This may have been coincident with the
emergence of modern humans from Africa, perhaps around
75,000 y ago (44). Molecular clock estimates have placed the P.
vivax most recent common ancestor (MRCA) at least 50,000–
70,000 y ago (6, 45), but these relied on rate assumptions that
may not be accurate. We have argued that the MRCA of P.
falciparum strains may have existed within the last 10,000 y (18)
despite molecular clock estimates that place the origin of that
species much earlier. Similarly, the MRCA of human P. vivax
may have left Africa in a more recent wave of human migration,
although its higher levels of genetic diversity (21) suggest that
human P. vivax is older than P. falciparum. Once out of Africa, P.
vivax spread through Asia and Europe and probably from
Europe into the Americas (39, 46). Strains of P. vivax now pre-
sent in Madagascar and East Africa, in areas where nonhuman
apes are absent, likely reflect reintroductions from Asia (47).
Given this historical isolation of ape and human P. vivax strains,
substantial gene flow between the two populations is unlikely.
The mixture of topologies found for different genes, with some
showing separation of the ape and human parasite lineages and
others having the human parasites nested within the radiation of
the ape parasites, likely reflects an ongoing process of lineage
sorting in the absence of introgression. However, this does not
mean that the two populations have become isolated species.
Both ape and human P. vivax exhibit broad natural tropism (7,
11, 15, 30), and it therefore seems very likely that ape and human
strains could infect the same hosts and undergo genetic exchange
if their geography overlapped. In recent years, reports of P. vivax
infection of African humans have been increasing, including in-
stances of infection of Duffy-negative individuals (4). It will be
important to monitor these cases to determine whether any re-
flect zoonotic transmissions from apes and whether there is any
sign of introgression between ape- and human-infecting strains.
Methods
Sample Collection, DNA Extraction, and Plasmodium Screening. Blood samples
were obtained from chimpanzees at the Sanaga-Yong Chimpanzee Rescue
Center following routine veterinary examination. Blood was also collected
from a wild-living habituated chimpanzee from the Tai Forest in Côte d’Ivoire
during emergency surgery (48). The gorilla blood sample (Gor3157, also re-
ferred to as “SAggg3157”) was obtained from confiscated bushmeat in
Cameroon. All samples were shipped in compliance with Convention on In-
ternational Trade in Endangered Species of Wild Fauna and Flora regulations
and country-specific import and export permits. DNA was extracted from
whole-blood samples using the QIAmp Blood DNA Mini Kit or the Puregene
Core Blood Kit (Qiagen) and was screened for Plasmodium using both pan-
Plasmodium primers and P. vivax-specific primers, as described (7, 9).
Amplicons were sequenced using Sanger or MiSeq technologies (SI Appendix).
SWGA. Nearly full-length and partial P. vivax genomes were amplified from
unprocessed chimpanzee and gorilla blood as described (18, 23) using mul-
tiple rounds of SWGA with different primer sets, with and without prior
digestion with MspJI and FspEI to selectively degrade host DNA (SI Appendix,
SI Materials and Methods and Table S1).
Illumina and PacBio Sequencing. Short insert libraries were prepared from
pooled SWGA products of samples SY43 and SY56 using a KAPA HyperPlus Kit
andwereMiSeq sequenced. Pooled SWGA products were also linearized with
S1 nuclease (Promega), needle-sheared to reduce fragment size, and sub-
jected to PacBio SMRT Cell sequencing (University of Delaware Sequencing
Core). SWGA products from samples SY81, SY90, Sagu, and Gor3157 were
Illumina sequenced to obtain partial P. vivax genomes (SI Appendix).
Assembly of Chimpanzee P. vivax Draft Genomes. Illumina sequencing reads
were error-corrected using SPAdes (49) and were mapped to the chimpanzee
reference genome; unmapped reads were mapped to the P. vivax
P01 reference genome (24). Regions with low coverage or poor paired-read
support were removed. Gaps were closed using FGAP (50) with proovread-
corrected PacBio reads (51) followed by iterations of GapFiller (52) and IM-
AGE (53). The PvSY56 draft genome was further improved by de novo
assembly of subtelomeric reads using SPAdes (49). Annotations were
transferred to the final assembly using RATT (54) and were predicted using
Companion (55) in the de novo-assembled subtelomeres, followed by
manual correction. Genome annotations for PvSY43 and PvSY56 are avail-
able upon request. Sets of orthologous genes from PvSY43, PvSY56, PvP01,
and PvSalI were masked using segmasker (nebc.nox.ac.uk/bioinformatics/
docs/blast+.html) to exclude low-complexity regions and were aligned using
TranslatorX/MUSCLE (56). Outgroup sequences, where available, were
added to these alignments using MUSCLE. Divergence between sequences
was calculated in R using ape (57) with no correction for multiple substitu-
tions (raw model). Fourfold and zerofold degenerate sites were extracted if
the classification was true for all sequences in the alignment (SI Appendix).
SNP Calling. In addition to sequencing SWGA products, we alsomined publicly
available databases for human (21) and chimpanzee (14) P. vivax reads. SNPs
were called following best practices for the Genome Analysis Toolkit with
hard filtering (58), using PvSY56 and PvP01 as ape and human P. vivax ref-
erence sequences, respectively. Regions classified as low-complexity by
dustmasker, genes in subtelomeric and internal hypervariable regions (20),
and all vir and phist genes were excluded. Sites with coverage of at least five
reads were considered callable, with genes containing fewer than 60% of
the sites of the reference excluded. Only sites callable for all strains were
analyzed. Site-frequency spectra were generated from high-quality SNP calls
for all high-coverage Southeast Asian P. vivax strains in the MalariaGEN
Genome Variation project (20). Fourfold and zerofold degenerate sites were
identified in the PvSalI reference sequence using custom R scripts, and de-
rived alleles at polymorphic sites were identified using the est-sfs unfolder
(59) with PvSY56 and P. cynomolgi as outgroups (SI Appendix).
SGA of Geographically Diverse P. vivax Strains. Ape P. vivax and P. carteri
sequences were amplified as described from stored ape blood and fecal
samples previously shown to be positive for these parasites (7). Fragments of
five genes were targeted using newly designed primers (SI Appendix).
Identification of rbp Genes. Chimpanzee P. vivax rbp genes were identified
during annotation of the PvSY56 and PvSY43 genomes. rbp orthologs
from P. malariae strain PmUG01 (14), P. knowlesi strain H (ref. 60, 2015 up-
date), P. cynomolgi strains B and Berok (61, 62), P. inui strain San Antonio 1,
and P. fragile strain Nilgiri (PlasmoDB) were identified from annotations and
using P. vivax rbp genes as query sequences. Human P. vivax sequencing reads
(20, 21) were downloaded and mapped to rbp2e (PVP01_0700500), rbp2p1
(PVP01_0534400), rbp2p2 (PVP01_101590), rbp3 (PVP01_1469400), and rbp2d
(PVP01_1471400 and PVX_101585), with a consensus sequence called for all
positions with threefold or greater coverage. The positions of frameshifts and
stop codons were identified relative to the ape P. vivax sequence (SI Appendix).
RBP Expression and Red Blood Cell-Binding Assays. Chimpanzee P. vivax rbp2d,
rbp2e, and rbp3 sequences were codon optimized, synthesized, and cloned
into pET-32a(+) (Novagen), yielding constructs RBP2d165–967, RBP2e156–957, and
RBP3149–968, respectively. Proteins were expressed using Escherichia coli SHuffle
T7 (New England Biolabs) and purified using a HisTrap (GE Healthcare) col-
umn. After hexahistidine tag cleavage and purification through a Q-Sepharose
HiTrap column (GE Healthcare), fractions containing the respective proteins
(determined by SDS PAGE) were concentrated and further purified by size-
exclusion chromatography. RBP2d165–967 could not be purified due to protein
aggregation. Expression and purification of two human P. vivax RBP proteins,
RBP2a160–1000 and RBP2b161–969, were performed as described (35, 36).
Whole blood from five chimpanzees (New Iberia Research Center), one
gorilla (Lincoln Park Zoo), and one rhesus macaque (BioIVT) was collected in
ACD-A collection tubes (BD Biosciences). All ape blood samples were leftover
specimens obtained during routine health screenings (the macaque blood
was purchased). Blood was also obtained from healthy human volunteers at
the University of Pennsylvania under Internal Review Board protocol 813699.
White blood cells were first removed by leukocyte filtration, and reticulocytes
were subsequently enriched by spinning red blood cells (50% hematocrit)
through a 65–75% (vol/vol) isotonic Percoll cushion and collecting the cell
band at the interface. To assess RBP binding, recombinant protein was in-
cubated with red blood cells for 1 h, followed by detection with an RBP-
specific polyclonal rabbit antibody and an anti-rabbit (Alexa Fluor 647-la-
beled) secondary antibody (Thermo Fisher Scientific). Between each in-
cubation step, cells were washed in 180 μL PBS containing 1% BSA (Sigma).
Cells were stained in the dark with BD Retic-Count reagent for 30 min at
room temperature, spun, and resuspended in 1.2 mL of PBS before analysis
on an Accuri flow cytometer (BD). Experiments were performed as three
technical replicates with the background signal from the antibody-only
control subtracted from each binding result (SI Appendix).
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